Best Chordoma doctors in Turkey: TOP 27 doctors

The doctor is a highly experienced Turkish medical oncologist specializing in sarcoma, lymphoma, pancreatic, lung cancer, and breast cancer. With over 20 years of experience, the doctor focuses on tumor biology, tumor immunology, cancer immunotherapy, and targeted therapies. Since 2019, the doctor has been serving as a medical oncologist at Anadolu Medical Center and previously held leadership roles at Istanbul Okan University Faculty of Medicine and GATA Haydarpaşa Training Hospital. The doctor has authored over 40 publications in cancer research and is a member of the Turkish Medical Oncology Association and the European Head and Neck Society.

Dr. Eda Tanrikulu, an Anadolu Medical Center oncologist, places in the top three in Turkey on the national medical oncology exam. She has served as a head researcher for multiple international cancer studies.

• Specializes in medical oncology and systemic chemotherapy treatments
• Former head of the medical oncology unit at Haydarpaşa Numune Training and Research Hospital
• Over 21 years of experience of medical training and practice since graduation
• Certified as a specialist in both internal medicine and medical oncology

Dr. Solak specializes in treating rare cancers like Chordoma, with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Completed fellowship at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Experienced in treating various complex cancers
• Specializes in breast, testicular, and gastrointestinal cancers

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Dr. Hasan Mutlu specializes in targeted cancer therapies and immunotherapy at Medical Park Antalya Hospital Complex.

• Trained in Medical Oncology at Akdeniz University
• Expert in next-generation genetic research for cancer treatment
• Associate Professor title in Medical Oncology
• Experience in complementary medicine approaches

Prof. Sezer Sağlam specializes in gastrointestinal oncology with extensive experience at Istanbul University's Oncology Institute.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University with focus on GI cancers
• Member of ESMO, ASCO, and European Neuroendocrine Tumour Society
• Works at Gayrettepe Florence Nightingale Hospital's Medical Oncology Department

Prof. Dr. Sefik Igdem specializes in radiation oncology, focusing on head and neck cancers and using advanced technologies like Truebeam Stx and Halcyons.

• Years of experience in radiation oncology
• Academic roles at T.R. Demiroğlu Bilim University
• Specializes in conformal treatments for precision
• Works at Gayrettepe Florence Nightingale Hospital

Assoc. Dr. Abdullah Sakin leads the Medical Oncology Department at Medipol Bahçelievler Hospital, specializing in chordoma and other complex oncological cases.

• Head of Medical Oncology at Yüzüncü Yıl University Faculty of Medicine
• Trained in Medical Oncology at İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi
• Extensive experience in both academic and clinical settings

Professor with 29 years of experience in medical oncology – Dr. Saglam specializes in gastrointestinal cancers at Istanbul Florence Nightingale Hospital.

• Completed fellowship at Istanbul University Oncology Institute
• Active member of ESMO and ASCO – follows international protocols
• Former attending physician for gastrointestinal oncology cases

Dr. Ozadli specializes in medical oncology with a strong focus on gastrointestinal and thoracic cancers at Valued Med Hub Hospitals.

• Completed medical oncology specialization at Ankara Oncology Training and Research Hospital
• Extensive experience in lung, esophageal, and gastric cancers
• Published researcher with work available on Google Scholar
• Practiced at multiple regional oncology centers across Turkey

Dr. Yildiz has published extensively on rare endocrine and oncologic conditions, with a focus on neuroendocrine tumors and paraneoplastic syndromes.

• 76 years of experience of experience in medical oncology
• Specializes in neuroendocrine tumors and complex cancer-related conditions
• Published 17+ peer-reviewed papers in international journals
• Practices at Medipol Mega University Hospital

Dr. Alemdar specializes in medical oncology at Medical Park Antalya Hospital Complex, with extensive training in internal medicine and oncology.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of medical experience across various hospitals
• Specialized training at Akdeniz University Faculty of Medicine
• Works with a multidisciplinary approach for comprehensive cancer care

Associate Professor Dr. Yusuf Acikgoz brings international expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in Medical Oncology with a focus on clinical trials
• Participated in Phase III studies like CheckMate-649 and Fortitude-101
• Member of American Society of Clinical Oncology (ASCO)
• Certified in Good Clinical Practice and Human Subjects Protection

Dr. Nail Paksoy brings specialized expertise in oncology, with a focus on complex cases at Medipol Bahçelievler Hospital.

• Board-certified in Medical Oncology by ESMO
• Published multiple studies on rare cancers and innovative treatments
• Active participant in international clinical trials for oncology
• Associate Professor at Istanbul Medipol University

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Topcu brings international expertise from MD Anderson and Sunnybrook Odette Cancer Center to Biruni University Hospital.

• Specializes in rare cancers including chordoma and sarcomas
• Member of ESMO and ASCO – global oncology standards
• Trained at top institutions in the US, Canada, and Turkey
• Works across multiple cancer types with complex cases